Injective (INJ) is among the top-performing altcoins on Monday as bullish sentiment sweeps the cryptocurrency market.
The token trades above $13.60, supported by renewed investor confidence after Bitcoin surged past $105,000.
Improving macroeconomic sentiment and favorable regulatory developments that support broader market momentum have led analysts to suggest Bitcoin may test new all-time highs in the near term.
This backdrop is fueling a rotation of capital into altcoins, with projects like Injective drawing increased speculative interest.
A layer-1 blockchain focused on decentralized finance and real-world asset (RWA) tokenization, Injective has continued to attract attention as narratives around scalability and use-case-driven growth gain traction.
Injective price extends gains above $10
The price of Injective (INJ) rose about 7% in the last 24 hours as major altcoins such as Ethereum, BNB and Solana reached key levels.
INJ jumped after breaking above the $10 threshold recently.
It currently changes hands around $13.62, having traded as high as $14.29 on May 12, 2025 — its highest level since late February.
Amid the price gains, Injective’s market capitalization reached $1.37 billion, while 24-hour trading volume remained modest at $172 million.
After rallying 46% over seven days and 67% over the past 30 days, broader market interest could allow bulls to seize control.
Bitcoin rally and RWA tokenization boost INJ price
Alongside Bitcoin’s rally, INJ’s price drivers include strong institutional demand within its RWA ecosystem.
Tokenization is a key tailwind for Injective, and recent industry reporting highlighted how this sector is helping INJ gain traction.
Previous bullish cycles have propelled DeFi, play-to-earn gaming, memecoins and AI tokens.
Today, analysts say growth in these areas combined with the expanding RWA market puts blockchains like Injective in the spotlight.
Injective’s network, designed to facilitate tokenization of traditional assets such as equities, stablecoins and commodities, stands to benefit.
Investors seeking on-chain exposure increasingly view it as a preferred platform.
Wider adoption of RWAs could further strengthen INJ’s price momentum.
Injective price technical outlook
From a technical perspective, INJ’s daily chart presents a bullish picture.
INJ chart on TradingView
The daily relative strength index (RSI) currently sits in overbought territory.
However, it is not excessively extended, suggesting there may still be room for buyers.
In the event of a pullback, INJ is likely to find support around $11.05 and $10.22.
This scenario aligns with the moving average convergence divergence (MACD), which shows a bullish crossover.
The MACD histogram points to upward momentum. If that momentum persists, bulls may target $16 and then $20.